Evidence map›Paper›PMID 26056361›Full record

ArticlePhilosophical transactions of the Royal Society of London. Series B, Biological sciences2015

Peto's paradox and the promise of comparative oncology.

Leonard Nunney, Carlo C Maley, Matthew Breen, Michael E Hochberg, Joshua D Schiffman

Open access · bronzeAbstract read
In one paragraph

Article in Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 83 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Do turtles get cancer?Bioscience · 2025
    Review
  6. Article
  7. No evidence for Peto's paradox in terrestrial vertebrates.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 2 countries.

Leonard NunneyDepartment of Biology, University of California Riverside, CA 92521, USA.
Carlo C MaleyBiodesign Institute, Arizona State University, Tempe, AZ 85287, USA Center for Evolution and Cancer, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94143, USA Centre for Evolution and Cancer, Institute for Cancer Research, London, UK.
Matthew BreenDepartment of Molecular Biomedical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27695, USA Center for Comparative Medicine and Translational Research, North Carolina State University, Raleigh, NC 27695, USA Center for Human Health and the Environment, North Carolina State University, Raleigh, NC 27695, USA Genetics Program, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27514, USA.
Michael E HochbergInstitut des Sciences de l'Evolution, Université Montpellier, UMR5554 du CNRS, Montpellier 34095, France Santa Fe Institute, 1399 Hyde Park Road, Santa Fe, NM 87501, USA.
Joshua D SchiffmanPrimary Children's Hospital (Intermountain Healthcare) and Huntsman Cancer Institute, Departments of Pediatrics and Oncological Sciences, University of Utah, Salt Lake City, UT 84112, USA joshua.schiffman@hci.utah.edu.
Arizona State University · USPrimary Children's Hospital · USUniversité de Montpellier · FRUniversity of California, Riverside · USUniversity of North Carolina at Chapel Hill · US

Funding

PHYLOGENIES of Barrett's Esophagus LineagesP01CA091955 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI GRADY, WILLIAM MALLORY · 2002 to 2019
$35.9M
Modeling Neoplastic Progression in Barrett's Esophagus - Renewal -2R01CA140657 · NCI · WISTAR INSTITUTE · PI Carlo Maley · 2009 to 2026
$5.0M
Stem Cells, Differentiation and Therapeutic Resistance in AMLR01CA149566 · NCI · UNIVERSITY OF PENNSYLVANIA · PI CARROLL, MARTIN · 2011 to 2015
$3.0M
Application of Evolutionary Principles to Maintain Cancer Control (PQ21)R01CA170595 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI GATENBY, ROBERT A · 2012 to 2015
$2.1M
(PQC3) Genomic Diversity and Microenvironment as Drivers of Metastasis in DCISR01CA185138 · NCI · DUKE UNIVERSITY · PI HWANG, E.SHELLEY, MALEY, CARLO · 2014 to 2017
$2.0M
NCI NIH HHS P01 CA091955NCI NIH HHS R01 CA140657NCI NIH HHS R01 CA170595NCI NIH HHS R01 CA185138
6 · The paper itself

Abstract

The past several decades have seen a paradigm shift with the integration of evolutionary thinking into studying cancer. The evolutionary lens is most commonly employed in understanding cancer emergence, tumour growth and metastasis, but there is an increasing realization that cancer defences both between tissues within the individual and between species have been influenced by natural selection. This special issue focuses on discoveries of these deeper evolutionary phenomena in the emerging area of 'comparative oncology'. Comparing cancer dynamics in different tissues or species can lead to insights into how biology and ecology have led to differences in carcinogenesis, and the diversity, incidence and lethality of cancers. In this introduction to the special issue, we review the history of the field and outline how the contributions use empirical, comparative and theoretical approaches to address the processes and patterns associated with 'Peto's paradox', the lack of a statistical relationship of cancer incidence with body size and longevity. This burgeoning area of research can help us understand that cancer is not only a disease but is also a driving force in biological systems and species life histories. Comparative oncology will be key to understanding globally important health issues, including cancer epidemiology, prevention and improved therapies.

Indexed as

Models, BiologicalAnimalsBiological EvolutionBody SizeCocarcinogenesisFemaleHumansLongevityMaleMammalsNeoplasmscancercomparative oncologyevolutionlife-history theorymodellingPeto's paradox

Identifiers

PMID26056361
PMCPMC4581022
OpenAlexW1858208649

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.